Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2011-12-09

View Filing

EFFECT - Notice of Effectiveness

Form Type: EFFECT

Filing Date: 2011-12-08

View Filing

S-1 - General form for registration of securities under the Securities Act of 1933

Form Type: S-1

Filing Date: 2011-11-23

View Filing

D - Notice of Exempt Offering of Securities

Form Type: D

Filing Date: 2011-11-15

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2011-11-02

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2011-10-03

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2011-09-12

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2011-08-31

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2011-08-29

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2011-07-12

View Filing